...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >ICD Versus VATS as Primary Treatment in Fibrinopurulent Stage of Empyema Thoracis
【24h】

ICD Versus VATS as Primary Treatment in Fibrinopurulent Stage of Empyema Thoracis

机译:ICD与VATS作为胸腔积脓性纤维化脓肿期的主要治疗方法

获取原文

摘要

Background and Objectives:Empyema thoracis is a condition in which pus collects in the pleural cavity. The optimal treatment of Empyema thoracis especially in the fibrinopurulent phase (Stage II) remains controversial. While the Inter Costal Drainage (ICD) is less invasive and cheap, it is not clearly proved that it is better than the Video Assisted Thoracoscopic Surgery (VATS) in terms of conversion into thoracotomy, morbidity and duration of hospital stay. No large randomized trial is available for comparing the two treatment strategies in the condition.Methodology:This study was a prospective comparative study of ICD insertion versus VATS as primary intervention in the fibrinopurulent stage of Empyema thoracis, which was conducted over a period of 2 years (Dec 2008 to Nov 2010), in a tertiarry care Medical College Hospital. With an incidence of around 5-10% and a considerable burden in our hospital, the study was taken up to compare the efficacy of ICD versus VATS, in terms of morbidity and cost effectiveness and to identify the optimal way of managing the condition. The study included a total of 40 patients with each group consisting of 20 patients.Sampling:Purposive sampling technique.The Statistical Methods Used:Descriptive statistics, Freque - ncies, Crosstabs, Independent sample t-test.Results:It was found that VATS was better than the conventional ICD insertion in terms of the variables like mean duration of hospital stay (p<0.05), mean duration of the chest tube in situ (p<0.05), mean cost of the treatment (p<0.05), complications (p<0.05) and failure rate (p<0.05) which were statistically significant.Conclusion:Our study concluded that Video Assisted Thor - acoscopic Surgery is better than conventional ICD tube insertion as a primary mode of treatment in the fibrinopurulent stage of Empyema thoracis.
机译:背景与目的:胸腔积液是脓液在胸膜腔积聚的病状。胸膜腔积脓的最佳治疗方法,尤其是在纤维化脓性阶段(II期),仍存在争议。尽管肋间引流术(ICD)的侵入性和价格较低,但尚未明确证明它在开胸手术,发病率和住院时间方面比电视胸腔镜手术(VATS)更好。没有大型的随机试验可用于比较该病的两种治疗策略。方法:本研究是对ICD插入与VATS进行的前瞻性比较研究,作为胸腔积脓的纤维化脓性阶段的主要干预措施,该研究历时2年(2008年12月至2010年11月)在一家三级护理医学院附属医院中。由于该病的发病率约为5-10%,并且在我院负担很重,因此该研究旨在比较ICD和VATS的疗效,发病率和成本效益,并确定治疗该病的最佳方法。研究共纳入40例患者,每组20例。抽样:目的抽样技术。统计方法采用描述性统计,频率,交叉表,独立样本t检验。结果:发现VATS为在诸如平均住院时间(p <0.05),平均原位胸管持续时间(p <0.05),平均治疗费用(p <0.05),并发症( p <0.05)和失败率(p <0.05)均具有统计学意义。结论:我们的研究得出结论,视频辅助的Thor-针镜手术比传统的ICD管插入术更适合于胸腔积脓的纤维化脓性阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号